Press Room

Contact Us

For submission information contact Susan Holtzman at

For more information on the VIVA Symposium or Late Breaking Clinical Trials, contact:

Susan O. Holtzman

More »

VIVA Livestreams

WATCH LIVE: VIVA 16 Late-Breaking Clinical Trial Press Conference
The above link will only be live during the live broadcast of the press conferences, beginning at 6:30 a.m. PT on Wednesday, September 21st.

Watch the highly anticipated Late-Breaking Clinical Trial Press Conferences live according to the schedule below.

Press Conference Schedule

Monday, September 19, 2016

Time Presentation Presenter
7:00 AM Introduction Michael R. Jaff, DO; Krishna Rocha-Singh, MD
7:05 AM MOBILE Clinical Trial:  MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects with Severe Peripheral ArteriaL DiseasE (PAD) Michael P. Murphy, MD, FACS
7:15 AM Safety and Performance of the Shockwave Lithoplasty® System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-phase DISRUPT PAD Study. Thomas Zeller, MD
7:25 AM Results from the IN.PACT SFA Randomized Trial Prakash Krishnan, MD
7:35 AM VIRTUS US Iliofemoral Stenting IDE Trial Stephen Black, MD
7:45 AM Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort Michael R. Jaff, DO

Tuesday, September 20, 2016

Time Presentation Presenter
6:30 AM Introduction Michael R. Jaff, DO; Krishna Rocha-Singh, MD
6:35 AM Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study Ali Azizzadeh, MD
6:45 AM Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry Zvonimir Krajcer, MD
6:55 AM Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach Charmaine Lok, MD, FRCPC
7:05 AM MAJESTIC 2 Year Results Plus Sub-group Analysis Stefan Müller-Hülsbeck, MD
7:15 AM 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study Antonio Micari, MD

Wednesday, September 21, 2016

Time Presentation Presenter
6:30 AM Introduction Michael R. Jaff, DO; Krishna Rocha-Singh, MD
6:35 AM ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries Richard Rapoza, MD
6:45 AM 12 Month Results from the DANCE Trial Atherectomy Cohort Chris Owens, MD
6:55 AM Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial John Laird Jr., MD
7:05 AM Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial Ido Weinberg, MD
7:15 AM Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial John Laird Jr., MD
7:25 AM PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery Richard Saxon, MD